Atlas Trials

Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

Clinical trial NCT06754163 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06754163
Sponsor
St Andrew's Healthcare
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Obesity and Obesity-related Medical ConditionsPsychiatric Disorders
Start date
2025-01-01
Primary completion
2027-07-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.